Optimizing Tildrakizumab Dosing in Psoriasis: A 52-Week Multicenter Retrospective Study Comparing 100 mg and 200 mg—IL PSO (Italian Landscape Psoriasis)

Our findings confirm the superior effectiveness of tildrakizumab 200 mg over 100 mg in specific subgroups of patients with a comparable safety profile across the study period.

Authors

Institutions

Publication Details

Journal
Dermatology and Therapy
Published
2025-04-23
DOI
https://doi.org/10.1007/s13555-025-01416-z
Citations
6
Primary Topic
Psoriasis: Treatment and Pathogenesis
Type
article
Field-Weighted Citation Impact
4.78
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Optimizing Tildrakizumab Dosing in Psoriasis: A 52-Week Multicenter Retrospective Study Comparing 100 mg and 200 mg—IL PSO (Italian Landscape Psoriasis)

Diego Orsini, Luca Rapparini, Angelo Valerio Marzano, Simone Ribero et al.
6 citations
Dermatology and Therapy
Psoriasis: Treatment and Pathogenesis
4.78
article

Optimizing Tildrakizumab Dosing in Psoriasis: A 52-Week Multicenter Retrospective Study Comparing 100 mg and 200 mg—IL PSO (Italian Landscape Psoriasis)

Diego Orsini, Luca Rapparini, Angelo Valerio Marzano, Simone Ribero, Anna Elisabetta Cagni, Francesco Loconsole, Romina Ortega, Luigi Gargiulo, Eugenia Veronica Di Brizzi, Matteo Megna, Claudio Guarneri, Emanuele Trovato, Leonardo Zichichi, Claudia Lasagni, Piergiorgio Malagoli, Pina Brianti, Paolo Dapavo, Aldo Cuccia, Marina Venturini, Santo Raffaele Mercuri, Valentina Dini, Antonio Costanzo, Anna Balato, Luca Potestio, Martina Burlando, Mario Valenti, Alessandra Michelucci, Luciano Ibba, Federico Bardazzi, Gaetano Licata, Andrea Carugno, Francesca Satolli, Norma Cameli, Alessandra Narcisi, Francesca Maria Gaiani, Maria Letizia Musumeci, S. Di Giulio, Maria Concetta Fargnoli, Carlo Giovanni Carrera, Davide Strippoli
article en
6 citations

Abstract

Our findings confirm the superior effectiveness of tildrakizumab 200 mg over 100 mg in specific subgroups of patients with a comparable safety profile across the study period.

Dermatology and TherapyVol. 15(6)
University of Siena (IT), University of Pisa (IT), University of Messina (IT), University of Insubria (IT), University of Modena and Reggio Emilia (IT), University of Parma (IT), Humanitas University (IT), Vita-Salute San Raffaele University (IT), University of Milan (IT), University of Campania "Luigi Vanvitelli" (IT), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), University of Catania (IT), IRCCS Policlinico San Donato (IT), Ospedale Sant Antonio (IT), Alessandro Manzoni Hospital (IT), Azienda USL di Bologna (IT), San Gallicano Hospital (IT), Austrian Society of Dermatology and Venereology (AT), Ospedale San Donato (IT), Ospedale Policlinico San Martino (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), IRCCS Humanitas Research Hospital (IT), Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT), University of Turin (IT), University of Bari Aldo Moro (IT), University of Naples Federico II (IT), University of Brescia (IT)
Openalex Percentile: Top 5%
Psoriasis: Treatment and Pathogenesis
4.78
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.